clinical trial · NCT06361186
Proximod Pharmacokinetics In Healthy Subjects
Rheumatoid ArthritisProximodPlacebo
brief summary
The goal of this clinical trial is to evaluate the tolerability, pharmacokinetics and pharmacodynamics of Proximod in healthy subjects. The main questions it arms to answer are: 1. to evaluate the safety and tolerance of Proximod in healthy subjects after single or repeated doses. 2. to learn the pharmacodynamics of Proximod in healthy subjects after single or repeated doses. 3. to evaluation of the effect of food on the pharmacokinetics of Proximod in healthy subjects Participants will receive test tablets or placebo at the indicated date and collect blood samples.
started
Sep 14, 2017
primary completion
Nov 1, 2017
completion
Jun 22, 2021
last updated
Apr 11, 2024
official title
A Single-center, Randomized, Double-blind, Placebo-controlled Phase I Study to Evaluate the Tolerability, Pharmacokinetics and Pharmacodynamics of Proximod in Healthy Subjects.
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol